Why the Administration Should Be Flexible with Medtech Tariffs to Protect Patients and Innovation
Flexibility on tariffs is critical to maintaining medtech as the backbone of the U.S. health care system and an American economic success story.
Emerging Policy Response Resources
2025 Emerging Policy Response Resources
Tariffs: Understanding the Nairobi Protocol and related Customs Procedures
Learn how the Nairobi Protocol may support duty-free access for medical devices under new tariffs.
Scott Whitaker Op-Ed: Tariffs Should Spare Vital U.S. MedTech Industry
A powerful op-ed from AdvaMed’s CEO explaining why tariffs could undermine U.S. medtech innovation, jobs, and patient care—and what must be done.
AdvaMed® Advancements: Q1 2025 Report
AdvaMed’s Q1 2025 report focuses on tariffs, policy action, and how we’re protecting Medtech innovation.
AdvaMed® Statement on President’s Reciprocal Tariff Pause
WASHINGTON – Today AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker:
Amendment To Reciprocal Tariffs and Updated Duties as Applied to Low-Value Imports from The People’s Republic of China
Details a sweeping tariff hike to 84% on Chinese imports and de minimis increases, aiming to protect U.S. economic and national security.
AdvaMed® Statement on Today’s Tariff Announcement
Washington, D.C.– AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker: “Our country is the birthplace of the medical device and technology industry and leads the…
Health Care Organizations on Concerns & Exemptions Regarding Tariffs
Tariffs on medical goods threaten healthcare costs, access, and supply chains. Leading health groups urge exemptions to safeguard patient care.
The Impact of Tariffs on Patient Access to Medical Technology
Tariffs on medtech could disrupt supply chains, increase costs, and delay care. Exemptions are needed to protect hospitals, patients, and innovation.
Make America Healthy Again Fact Sheet
An overview of the Make America Healthy Again Commission, its mission to address chronic disease in the U.S., and policy initiatives aimed at improving public health.